Does OLMESARTAN MEDOXOMIL Cause Off label use? 220 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 220 reports of Off label use have been filed in association with OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL). This represents 1.8% of all adverse event reports for OLMESARTAN MEDOXOMIL.
220
Reports of Off label use with OLMESARTAN MEDOXOMIL
1.8%
of all OLMESARTAN MEDOXOMIL reports
6
Deaths
74
Hospitalizations
How Dangerous Is Off label use From OLMESARTAN MEDOXOMIL?
Of the 220 reports, 6 (2.7%) resulted in death, 74 (33.6%) required hospitalization, and 4 (1.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLMESARTAN MEDOXOMIL. However, 220 reports have been filed with the FAERS database.
What Other Side Effects Does OLMESARTAN MEDOXOMIL Cause?
Sprue-like enteropathy (3,482)
Gastrooesophageal reflux disease (1,819)
Acute kidney injury (1,587)
Weight decreased (1,569)
Haemorrhoids (1,316)
Diarrhoea (1,300)
Hiatus hernia (938)
Dizziness (885)
Large intestine polyp (839)
Constipation (796)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which OLMESARTAN MEDOXOMIL Alternatives Have Lower Off label use Risk?
OLMESARTAN MEDOXOMIL vs OLMETEC
OLMESARTAN MEDOXOMIL vs OLODATEROL
OLMESARTAN MEDOXOMIL vs OLODATEROL\TIOTROPIUM
OLMESARTAN MEDOXOMIL vs OLOPATADINE
OLMESARTAN MEDOXOMIL vs OLUTASIDENIB